Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
142.44
+1.19 (0.84%)
Oct 9, 2026, 4:00 PM EDT - Market closed

Neurocrine Biosciences Market Cap

Neurocrine Biosciences has a market cap or net worth of $14.48 billion as of October 9, 2026. It is the 1,571st most valuable company in the world and the 583rd biggest in the United States. Its market cap has increased by 4.96% in one year.

Market Cap
14.48B
Enterprise Value
14.55B
1-Year Change
4.96%
Global Rank
Country Rank
#583 United States
Category

Chart

Chart

Since December 1, 1998, Neurocrine Biosciences's market cap has increased from $124.10M to $14.48B, an increase of 11,567.13%. That is a compound annual growth rate of 18.62%.

History

DateMarket Cap% Change
Oct 9, 202614.48B2.39%
Dec 31, 202514.14B2.32%
Dec 31, 202413.82B6.76%
Dec 29, 202312.95B12.74%
Dec 30, 202211.48B42.11%
Dec 31, 20218.08B-9.78%
Dec 31, 20208.96B-9.54%
Dec 31, 20199.90B52.87%
Dec 31, 20186.48B-5.69%
Dec 29, 20176.87B104.24%
Dec 30, 20163.36B-31.05%
Dec 31, 20154.88B187.17%
Dec 31, 20141.70B169.95%
Dec 31, 2013629.00M26.66%
Dec 31, 2012496.60M5.73%
Dec 30, 2011469.70M12.07%
Dec 31, 2010419.10M293.15%
Dec 31, 2009106.60M-13.68%
Dec 31, 2008123.50M-28.41%
Dec 31, 2007172.50M-56.31%
Dec 29, 2006394.80M-82.96%
Dec 30, 20052.32B28.86%
Dec 31, 20041.80B-6.54%
Dec 31, 20031.92B37.67%
Dec 31, 20021.40B3.88%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding